STUDY OF THE EFFICIENCY AND SAFETY OF MYCOPHENOLATE MOFETIL THERAPY IN PATIENTSWITH SYSTEMIC SCLERODERMA

Interstitial lung disease (ILD) is one of the major causes of death in systemic scleroderma (SSD). Treatment of these patients remains difficult and controversial. Mycophenolate mofetil (MPM) has been in vitro shown to inhibit overproduction of type I collagen and hence may be effective against SSD....

ver descrição completa

Detalhes bibliográficos

Principais autores:	O A Koneva, L P Ananyeva, O B Ovsyannikova, L V Teplova, M N Starovoitova, O V Desinova, T A Nevskaya, R T Alekperov, E G Lyubimova, L N Denisov
Formato:	Artigo
Idioma:	Russo
Publicado em:	IMA PRESS LLC 2011-08-01
Colecção:	Научно-практическая ревматология
Assuntos:	interstitial lung disease lung involvement, systemic scleroderma mycophenolate mofetil
Acesso em linha:	https://rsp.mediar-press.net/rsp/article/view/340
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!